Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Niraparib (ZEJULA)
Niraparib (ZEJULA)
On March 27, 2017 , the U.
Chinese drug approval boosts AstraZeneca's lung cancer hopes
Chinese drug approval boosts AstraZeneca's lung cancer hopes
AstraZeneca has won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine.
Mylan closing Illinois plant, cutting 90 jobs as part of slim-down after Meda buyout
Mylan closing Illinois plant, cutting 90 jobs as part of slim-down after Meda buyout
Mylan has been in the midst of whacking about 3,500 jobs to cut costs and refocus after its $7 billion buyout last year of Meda Pharmaceuticals.
Australia slashes prescription prices across therapeutic areas
Australia slashes prescription prices across therapeutic areas
The Australian government is reducing the price of 1,100 medicine brands listed on the Pharmaceutical Benefits Scheme.
Amgen's Humira Biosimilar Approved in Europe
Amgen's Humira Biosimilar Approved in Europe
Amgen Inc.
EU recommends suspending hundreds of drugs tested by Indian firm
EU recommends suspending hundreds of drugs tested by Indian firm
Europe's medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to "unreliable" tests conducted by Indian contract research ...
Vitamin C, when administered in high doses by intravenous (I.V.) infusions, can kill cancer cells
Vitamin C, when administered in high doses by intravenous (I.V.) infusions, can kill cancer cells
Vitamin C interacts with iron and other metals to create hydrogen peroxide.
FDA Approves Symproic (naldemedine) for the Treatment of Opioid-Induced Constipation
FDA Approves Symproic (naldemedine) for the Treatment of Opioid-Induced Constipation
OSAKA, Japan and FLORHAM PARK, N.
FDA approves first treatment for rare form of skin cancer
FDA approves first treatment for rare form of skin cancer
The U.
Teva looks to reduce costs "in every area"
Teva looks to reduce costs "in every area"
Israeli generics specialist Teva Pharmaceutical (NYSE.
Sanofi on verge of $1B-plus deal for arthritis-focused biotech Flexion: source
Sanofi on verge of $1B-plus deal for arthritis-focused biotech Flexion: source
Sanofi is in talks to buy Flexion Therapeutics, a Boston-area biotech with its lead product now awaiting FDA approval, for more than $1 billion in cash, according to a source close to the deal.
Akashi Therapeutics Receives FDA Clearance to Resume HT-100 Clinical Development
Akashi Therapeutics Receives FDA Clearance to Resume HT-100 Clinical Development
CAMBRIDGE, MA, USA I March 22, 2017 I Akashi Therapeutics Inc.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand